Time on boards
- Boards served
- 3
- Current seats
- 3
- Board service
- 10 years
- Director since
- 2023
10 years of board service in total across 3 boards, counting each seat separately. Longest: Enanta Pharmaceuticals Inc., 3 years.
Enanta Pharmaceuticals Inc.
Director
AMN Healthcare Services Inc
Director
DexCom Inc.
Director
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Aug 3, 2026 | DexCom Inc. | Open-market sale | −2,000 | $85.32 | $170,640 |
| Jul 31, 2026 | DexCom Inc. | Open-market sale | −2,000 | $80.00 | $160,000 |
| Jun 15, 2026 | DexCom Inc. | Open-market sale | −3,801 | $74.10 | $281,654 |
| Jun 15, 2026 | AMN Healthcare Services Inc | Open-market sale | −1,681 | $31.07 | $52,229 |
| Jun 15, 2026 | DexCom Inc. | Open-market sale | −199 | $74.82 | $14,889 |
| Jun 15, 2026 | AMN Healthcare Services Inc | Open-market sale | −2,000 | $31.07 | $62,140 |
| May 28, 2026 | DexCom Inc. | Grant or award | +6,331 | — | — |
| May 8, 2026 | DexCom Inc. | Gift | −5,731 | — | — |
| May 8, 2026 | DexCom Inc. | Gift | +5,731 | — | — |
| May 1, 2026 | AMN Healthcare Services Inc | Option exercise | +8,325 | — | — |
| Aug 15, 2025 | DexCom Inc. | Open-market sale | −2,555 | $81.02 | $207,006 |
| Aug 15, 2025 | DexCom Inc. | Open-market sale | −195 | $81.54 | $15,900 |
| Jul 15, 2025 | DexCom Inc. | Open-market sale | −2,742 | $85.17 | $233,536 |
| Jul 15, 2025 | DexCom Inc. | Open-market sale | −8 | $86.03 | $688 |
| Jun 16, 2025 | DexCom Inc. | Open-market sale | −2,750 | $83.13 | $228,608 |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.